Association of primary tumor radiomic phenotypes and outcomes in patients (pts) with metastatic renal cell clear cell carcinoma (mRCC) treated with cytoreductive nephrectomy (CN).

被引：0
|
作者：
Cunha, Mateus Trinconi
Stangler, Lucas
Freire, Pedro
Alves Pinto, Paulo Victor
Almeida Coelho, Fernando Morbeck
Viana, Publio
Cordeiro, Mauricio
Nahas, William Carlos
Mota, Jose Mauricio
机构：
[1] Univ Sao Paulo, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
[2] Univ Sao Paulo, Inst Radiol, Sao Paulo, Brazil
[3] Univ Sao Paulo, Dept Radiol, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
[4] Univ Sao Paulo, Dept Urol, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
622
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Outcomes of patients (pts) with metastatic non-clear-cell renal cell carcinoma (nccRCC) treated with pazopanib
    Matrana, Marc Ryan
    Baiomy, Ali
    Elsayes, Khaled M.
    Shetty, Aditya
    Teegavarapu, Purnima Sravanti
    Xiao, Lianchun
    Jonasch, Eric
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [22] Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma
    Bex, Axel
    Albiges, Laurence
    Ljungberg, Borje
    Bensalah, Karim
    Dabestani, Saeed
    Giles, Rachel H.
    Hofmann, Fabian
    Hora, Milan
    Kuczyk, Markus A.
    Lam, Thomas B.
    Marconi, Lorenzo
    Merseburger, Axel S.
    Fernandez-Pello, Sergio
    Tahbaz, Rana
    Abu-Ghanem, Yasmin
    Staehler, Michael
    Volpe, Alessandro
    Powles, Thomas
    EUROPEAN UROLOGY, 2018, 74 (06) : 805 - 809
  • [23] SHOULD PATIENTS WITH METASTATIC NON-CLEAR CELL RENAL CELL CARCINOMA UNDERGO CYTOREDUCTIVE NEPHRECTOMY?
    Keskin, Sarp
    Petros, Firas
    Yu, Kai-jie
    Aboshady, Yara
    Borregales, Leonardo
    Kenney, Patrick
    Matin, Surena
    Karam, Jose
    Wood, Christopher
    JOURNAL OF UROLOGY, 2017, 197 (04) : E65 - E66
  • [24] CABOPRE: A phase II study of cabozantinib (cabo) prior cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC)
    De Velasco, G.
    Alonso-Gordoa, T.
    Rodriguez-Moreno, J. F.
    Duran, I.
    Carretero-Gonzalez, A.
    Martin-Soberon, M.
    Gutierrez Banos, J. L.
    Guerrero-Ramos, F.
    Duenas, M.
    Castellano Gauna, D.
    ANNALS OF ONCOLOGY, 2021, 32 : S698 - S699
  • [25] Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma
    Laukhtina, Ekaterina
    Pradere, Benjamin
    Andrea, David D.
    Rosiello, Giuseppe
    Luzzago, Stefano
    Pecoraro, Angela
    Palumbo, Carlotta
    Knipper, Sophie
    Karakiewicz, Pierre, I
    Margulis, Vitaly
    Quhal, Fahad
    Motlagh, Reza Sari
    Mostafaei, Hadi
    Mori, Keiichiro
    Kimura, Shoji
    Enikeev, Dmitry
    Shariat, Shahrokh F.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) : 936.e7 - 936.e14
  • [26] Cytoreductive nephrectomy in metastatic renal cell carcinoma
    Mattigk, Angelika
    Zengerling, Friedemann
    UROLOGIE, 2024, 63 (11): : 1151 - 1154
  • [27] Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
    Chery, Lisly J.
    Karam, Jose A.
    Wood, Christopher G.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (09) : 696 - 703
  • [28] Cytoreductive nephrectomy in metastatic renal cell carcinoma
    Healy, Kelly A.
    Marshall, Fray F.
    Ogan, Kenneth
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (08) : 1295 - 1304
  • [29] Cytoreductive nephrectomy for metastatic renal cell carcinoma
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2023, 54 (04) : 270 - 271
  • [30] Cytoreductive nephrectomy in metastatic renal cell carcinoma
    Margulis, Vitaly
    Matin, Surena F.
    Wood, Christopher G.
    CURRENT OPINION IN UROLOGY, 2008, 18 (05) : 474 - 480
12345